Carcinoma Industry, April 2015 Market Reports from Top Publishers

You might be interested in: Diagnostics, Drug, Oncology.


 
1-10 of 64 reports for Carcinoma

Purchase Reports From Reputable Market Research Publishers

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2014

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2014’, provides an overview ...

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2015

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Global Markets Direct

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2015’, provides an overview ...

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2015

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Global Markets Direct

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2015’, provides an overview ...

Renal Cell Carcinoma: KOL Insight

Renal Cell Carcinoma: KOL Insight

  • $ 6 695
  • Industry report
  • February 2015
  • by Firstword Pharma

Will new checkpoint inhibitors revive immunotherapy in RCC? Renal Cell Carcinoma: KOL Insight offers opinions of 12 leading US and European KOLs that present business-critical insights for branded pharma ...

Metastatic Renal Cell Carcinoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Metastatic Renal Cell Carcinoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Metastatic Renal Cell Carcinoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and ...

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Metastatic Renal ...

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014’, ...

EpiCast Report: Cushing’s Syndrome - Epidemiology Forecast to 2023

EpiCast Report: Cushing’s Syndrome - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • December 2014
  • by Global Data

EpiCast Report: Cushing’s Syndrome - Epidemiology Forecast to 2023 Summary Cushing’s syndrome (CS) is a rare disorder caused by prolonged exposure to excess amounts of circulating free glucocorticoids, ...

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014’, provides an overview ...

Hepatocellular Carcinoma - Pipeline Review, H2 2014

Hepatocellular Carcinoma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Hepatocellular Carcinoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Hepatocellular Carcinoma’s ...

About 4 300 reports for Carcinoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2013
    82 pages
  • Carcinoma  

    Cancer  

  • United States  

View report >

Pathology Description

August 2013

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.